Synthesis and radiolabeling of diabody fragment of anti-PD-L1-B11 antibody for PET imaging of PD-L1 in a melanoma tumor mouse model

被引：0
|
作者：
Bansal, Aditya [1 ]
Lavoie, Roxane [1 ]
Lucien, Fabrice [1 ]
Kethamreddy, Manasa [1 ]
Dong, Haidong [1 ]
Park, Sean [1 ]
Pandey, Mukesh [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2023年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-179
引用
收藏
页码：S193 / S194
页数：2
相关论文
共 50 条
  • [41] PD-L1 Antibody Pharmacokinetics and Tumor Targeting in Mouse Models for Infectious Diseases
    Sandker, Gerwin G. W.
    Adema, Gosse
    Molkenboer-Kuenen, Janneke
    Wierstra, Peter
    Bussink, Johan
    Heskamp, Sandra
    Aarntzen, Erik H. J. G.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [42] PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody
    Lv, Gaochao
    Sun, Xiaorong
    Qiu, Ling
    Sun, Yan
    Li, Ke
    Liu, Qingzhu
    Zhao, Qi
    Qin, Songbing
    Lin, Jianguo
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (01) : 117 - 122
  • [43] PD-L1 expression in equine malignant melanoma and functional effects of PD-L1 blockade
    Ganbaatar, Otgontuya
    Konnai, Satoru
    Okagawa, Tomohiro
    Nojima, Yutaro
    Maekawa, Naoya
    Minato, Erina
    Kobayashi, Atsushi
    Ando, Ryo
    Sasaki, Nobuya
    Miyakoshi, Daisuke
    Ichii, Osamu
    Kato, Yukinari
    Suzuki, Yasuhiko
    Murata, Shiro
    Ohashi, Kazuhiko
    PLOS ONE, 2020, 15 (11):
  • [44] Optimizing Immuno-PET Imaging of Tumor PD-L1 Expression: Pharmacokinetic, Biodistribution, and Dosimetric Comparisons of 89Zr-Labeled Anti-PD-L1 Antibody Formats
    Bouleau, Alizee
    Nozach, Herve
    Dubois, Steven
    Kereselidze, Dimitri
    Chevaleyre, Celine
    Wang, Cheng-, I
    Evans, Michael J.
    Lebon, Vincent
    Maillere, Bernard
    Truillet, Charles
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (08) : 1259 - 1265
  • [45] 89Zr-Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
    Jung, Kyung-Ho
    Park, Jin Won
    Lee, Jin Hee
    Moon, Seung Hwan
    Cho, Young Seok
    Lee, Kyung-Han
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (05) : 656 - 664
  • [46] PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison
    Sunshine, Joel C.
    Nguyen, Peter L.
    Kaunitz, Genevieve J.
    Cottrell, Tricia R.
    Berry, Sneha
    Esandrio, Jessica
    Xu, Haiying
    Ogurtsova, Aleksandra
    Bleich, Karen B.
    Cornish, Toby C.
    Lipson, Evan J.
    Anders, Robert A.
    Taube, Janis M.
    CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4938 - 4944
  • [47] Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy
    Margarita Kirienko
    Martina Sollini
    Arturo Chiti
    Clinical and Translational Imaging, 2018, 6 : 417 - 427
  • [48] Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy
    Kirienko, Margarita
    Sollini, Martina
    Chiti, Arturo
    CLINICAL AND TRANSLATIONAL IMAGING, 2018, 6 (06) : 417 - 427
  • [49] PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials
    Madore, Jason
    Vilain, Ricardo E.
    Menzies, Alexander M.
    Kakavand, Hojabr
    Wilmott, James S.
    Hyman, Jessica
    Yearley, Jennifer H.
    Kefford, Richard F.
    Thompson, John F.
    Long, Georgina V.
    Hersey, Peter
    Scolyer, Richard A.
    PIGMENT CELL & MELANOMA RESEARCH, 2015, 28 (03) : 245 - 253
  • [50] Emerging biomarkers as predictors to anti-PD1/PD-L1 therapies in advanced melanoma
    Loo, Kimberly
    Daud, Adil
    IMMUNOTHERAPY, 2016, 8 (07) : 775 - 784
12345